Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Sumit A. Shah · SciRah

Researcher profile · Semantic Scholar

Sumit A. Shah

Share profile

Sumit A. Shah — researcher profile on SciRah

h-index: 18
Works: 87
Citations: 3,118

Most-cited papers

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
N. Kuderer, T. Choueiri, D. Shah, Y. Shyr +232 more
2020The Lancet1,565 citations Open access
Semantic Scholar
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.
B. Sikic, N. Lakhani, A. Patnaik, Sumit A. Shah +26 more
2016Journal of Clinical Oncology476 citations Open access
Semantic Scholar
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study
N. M. Chanzá, Wan-Ling Xie, M. Bilen, H. Dzimitrowicz +34 more
2019The Lancet Oncology151 citations Open access
Semantic Scholar
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study
D. Rivera, S. Peters, O. Panagiotou, D. Shah +41 more
2020Cancer Discovery122 citations Open access
Semantic Scholar
Myocarditis Surveillance with High-Sensitivity Troponin I During Cancer Treatment with Immune Checkpoint Inhibitors
Sarah Waliany, J. Neal, S. Reddy, H. Wakelee +8 more
2021JACC CardioOncology106 citations Open access
Semantic Scholar
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
V. Koshkin, N. Henderson, M. James, D. Natesan +32 more
2021Cancer86 citations Open access
Semantic Scholar
PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer
L. Baratto, Hong Song, He-Ying Duan, N. Hatami +9 more
2021Journal of Nuclear Medicine66 citations Open access
Semantic Scholar
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
Z. Bakouny, C. Labaki, P. Grover, J. Awosika +72 more
2022JAMA Oncology45 citations Open access
Semantic Scholar
Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer.
H. Bhambhvani, A. Zamora, E. Shkolyar, Kris Prado +7 more
2020Urologic oncology43 citations
Semantic Scholar
NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025.
T. Gilligan, Daniel W. Lin, N. Adra, A. Bagrodia +31 more
2025The Journal of the National Comprehensive Cancer Network33 citations
Semantic Scholar
Remote Oncology Care: Review of Current Technology and Future Directions
B. McGregor, G. Vidal, Sumit A. Shah, James D. Mitchell +1 more
2020Cureus30 citations Open access
Semantic Scholar
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study
Nieves Martínez Chanzá, Wan-Ling Xie, M. Issa, H. Dzimitrowicz +16 more
2020Journal for ImmunoTherapy of Cancer28 citations Open access
Semantic Scholar
A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance
M. Abidi, D. Aboulafia, M. Accordino, J. Acoba +278 more
2020Cancer Cell26 citations Open access
Semantic Scholar
Consolidative Radiotherapy in Metastatic Urothelial Cancer
Sumit A. Shah, C. Zhang, S. Hancock, Alice C. Fan +2 more
2017Clinical Genitourinary Cancer24 citations
Semantic Scholar
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
Hong Song, Maria Isabel Leonio, V. Ferri, He-Ying Duan +11 more
2024European Journal of Nuclear Medicine and Molecular Imaging22 citations
Semantic Scholar
Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19).
J. Warner, S. Rubinstein, P. Grivas, T. Choueiri +16 more
2020Journal of Clinical Oncology21 citations
Semantic Scholar
Use of Machine Learning and Lay Care Coaches to Increase Advance Care Planning Conversations for Patients With Metastatic Cancer
M. Gensheimer, Divya Gupta, Manali I. Patel, T. Fardeen +29 more
2022JCO Oncology Practice18 citations
Semantic Scholar
Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancer
O. Generalova, M. Roy, Evan Hall, Sumit A. Shah +17 more
2021Journal of Patient-Reported Outcomes18 citations Open access
Semantic Scholar
Under-treatment of high-risk localized prostate cancer in the California Latino population
D. Lichtensztajn, J. Leppert, J. Brooks, Sumit A. Shah +4 more
2018The Journal of the National Comprehensive Cancer Network18 citations Open access
Semantic Scholar
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study
G. Satyanarayana, Kyle T. Enriquez, Tianyi Sun, Elizabeth J Klein +53 more
2022Open Forum Infectious Diseases17 citations Open access
Semantic Scholar
Changes in Cancer Management due to COVID-19 Illness in Patients with Cancer in Northern California.
J. Wu, D. Kwon, M. Glover, S. Henry +5 more
2020JCO Oncology Practice17 citations Open access
Semantic Scholar
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study.
Tanya Jindal, Cindy Y. Jiang, O. Alhalabi, C. Nguyen +34 more
2025European Urology15 citations
Semantic Scholar
Associations of Renal Cell Carcinoma Subtype with Patient Demographics, Comorbidities, and Neighborhood Socioeconomic Status in the California Population
D. Lichtensztajn, Brenda M. Hofer, J. Leppert, J. Brooks +4 more
2022Cancer Epidemiology, Biomarkers and Prevention14 citations Open access
Semantic Scholar
Treatment‐Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study
A. Nizam, Charles B. Nguyen, Jin-Ju Li, Emily C. Zabor +35 more
2025Cancer Medicine12 citations Open access
Semantic Scholar
In Patients with Advanced Urothelial Carcinoma, Immune Checkpoint Inhibition Prior to Enfortumab Vedotin Is Associated with High-grade Skin Toxicity.
G. Molina, B. Schwartz, S. Srinivas, Sumit A. Shah +1 more
2023European Urology12 citations Open access
Semantic Scholar
A first-in-class, first-in-human phase 1 pharmacokinetic (PK) and pharmacodynamic (PD) study of Hu5F9-G4, an anti-CD47 monoclonal antibody (mAb), in patients with advanced solid tumors.
B. Sikic, N. Lakhani, A. Patnaik, Sumit A. Shah +16 more
201812 citations
Semantic Scholar
Lay healthcare worker financial toxicity intervention: a pilot financial toxicity screening and referral program
Divya A. Parikh, Gladys M Rodriguez, M. Ragavan, Elizabeth Kerr +6 more
2024Supportive Care in Cancer10 citations Open access
Semantic Scholar
Independent biomarkers predictive of outcomes with enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.
Tanya Jindal, Li Zhang, Cindy Y. Jiang, D. Kilari +16 more
2023Journal of Clinical Oncology10 citations
Semantic Scholar
Testicular cancer in Hispanics: incidence of subtypes over time according to neighborhood sociodemographic factors in California
Mindy C. Derouen, M. McKinley, Sumit A. Shah, H. Borno +7 more
2020Cancer Causes and Control10 citations
Semantic Scholar
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data.
Tanya Jindal, Cindy Y. Jiang, O. Alhalabi, A. Nizam +28 more
2024European Urology Oncology9 citations Open access
Semantic Scholar
Coaches Activating, Reaching, and Engaging Patients to Engage in Advance Care Planning: A Randomized Clinical Trial.
Gladys M Rodriguez, Divya A. Parikh, K. Kapphahn, Divya M Gupta +10 more
2024JAMA Oncology9 citations Open access
Semantic Scholar
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a CCC19 registry analysis.
S. Rubinstein, Divaya Bhutani, R. Lynch, Chih-Yuan Hsu +56 more
2022Blood Cancer Discovery9 citations Open access
Semantic Scholar
Biomarkers of response to enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.
Tanya Jindal, D. Kilari, O. Alhalabi, A. Nizam +16 more
2023Journal of Clinical Oncology7 citations Open access
Semantic Scholar
Racial and socioeconomic disparities in retroperitoneal lymph node dissection and survival in nonseminomatous germ cell tumor: A population-based study.
H. Bhambhvani, Daniel R. Greenberg, Alex M. Kasman, Mindy C. Derouen +3 more
2021Urologic oncology7 citations
Semantic Scholar
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States
J. Hawley, Tianyi Sun, D. Chism, N. Duma +45 more
2022JAMA Network Open6 citations Open access
Semantic Scholar
Enfortumab vedotin (EV) outcomes with and without immediate prior immune checkpoint inhibitor (ICI) in patients (pts) with advanced urothelial carcinoma (aUC).
V. Koshkin, N. Henderson, D. Kilari, Tanya Jindal +16 more
2023Journal of Clinical Oncology4 citations
Semantic Scholar
Cabozantinib (Cabo) in advanced non-clear cell renal cell carcinoma (nccRCC): A retrospective multicenter analysis.
N. M. Chanzá, D. Bossé, M. Bilen, D. Geynisman +16 more
20184 citations
Semantic Scholar
Association of tumor-informed ctDNA-based molecular residual disease (MRD) with clinical outcomes for upper tract urothelial cancer (UTUC).
Adanma Ayanambakkam, G. Laliotis, K. Reyes, Beaux Mitchell +13 more
2025Journal of Clinical Oncology3 citations
Semantic Scholar
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study
Cindy Y. Jiang, H. Hwang, Ilana Y. Epstein, D. Bakaloudi +31 more
2025The Oncologist2 citations Open access
Semantic Scholar
On Aligning Prediction Models with Clinical Experiential Learning: A Prostate Cancer Case Study
J. J. Vallon, William Overman, Wanqiao Xu, N. Panjwani +10 more
2025arXiv.org2 citations
Semantic Scholar
Outcomes of enfortumab vedotin and pembrolizumab for patients previously treated with immune checkpoint inhibitors in the UNITE study.
Tanya Jindal, Cindy Y. Jiang, O. Alhalabi, F. Sidhom +16 more
2025Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Clinical Response to Enfortumab Vedotin and Pembrolizumab in a Patient with Vaginal Squamous Cell Carcinoma: A Case Report
Michael J. Glover, Isabel Beshar, Austin McHenry, Cornelia Ding +3 more
2025Case Reports in Oncology2 citations Open access
Semantic Scholar
Assessing the clinical utility of rapid post-therapy whole-body digital SPECT/CT in evaluating early treatment response of 177Lu-PSMA-617 treatment.
Hong Song, Maria Isabel Leonio, V. Ferri, He-Ying Duan +11 more
2024Journal of Clinical Oncology2 citations
Semantic Scholar
Outcomes with neoadjuvant chemotherapy in bladder-preserving treatment for MIBC.
Michael J. Glover, A. Ewongwo, M. Usoz, Z. Kornberg +4 more
2024Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Impact of squamous histology on outcomes with enfortumab vedotin in patients with advanced urothelial carcinoma: Analysis of the UNITE study.
Tanya Jindal, O. Alhalabi, C. Nguyen, D. Bakaloudi +16 more
2024Journal of Clinical Oncology2 citations
Semantic Scholar
Association of tumor-informed minimal residual disease (MRD) with clinical outcomes for muscle invasive bladder cancer (MIBC): A multicenter retrospective real-world analysis.
Ajitha Kommalapati, G. Laliotis, M. Glover, Grayce Selig +14 more
2023Journal of Clinical Oncology2 citations Open access
Semantic Scholar
COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease
Melissa Y. Y. Moey, C. Hennessy, B. French, J. Warner +63 more
2023Translational Oncology2 citations Open access
Semantic Scholar
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma
Douglas B. Johnson, M. Atkins, C. Hennessy, Trisha Wise-Draper +35 more
2023BMC Cancer2 citations Open access
Semantic Scholar
Use of a computer model and care coaches to increase advance care planning conversations for patients with metastatic cancer.
Divyansh Gupta, T. Fardeen, Winifred Teuteberg, Briththa Seevaratnam +16 more
2021Journal of Clinical Oncology2 citations
Semantic Scholar
Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database.
Albert Jang, Tanya Jindal, A. Khaki, Cindy Y. Jiang +35 more
2026Clinical Genitourinary Cancer1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Bilen×18
Invite
M. Bilen — researcher profile on SciRah
V. Koshkin×18
Invite
V. Koshkin — researcher profile on SciRah
P. Grivas×15
Invite
P. Grivas — researcher profile on SciRah
A. Khaki×13
Invite
A. Khaki — researcher profile on SciRah

×13

Invite

Y. Zakharia — researcher profile on SciRah

Invite

A. Nizam — researcher profile on SciRah

Shilpa Gupta×12

Invite

Shilpa Gupta — researcher profile on SciRah

Tanya Jindal×11

Invite

Tanya Jindal — researcher profile on SciRah

H. Emamekhoo×11

Invite

H. Emamekhoo — researcher profile on SciRah

Invite

A. Alva — researcher profile on SciRah

Invite

C. Hoimes — researcher profile on SciRah

O. Alhalabi×10

Invite

O. Alhalabi — researcher profile on SciRah